WANG Yizhu, LIU Fang, ZHANG Xianglin. Application of Oral Chinese Patent Medicine in Corona Virus Disease-19[J]. 2020,20(3):257-261. DOI: 10.14009/j.issn.1672-2124.2020.03.001.
Corona virus disease-19( COVID-19) epidemic lasts for nearly 3 months
different Chinese and Western medicine treatment regimens are recommended. The National Health Commission of the People’s Republic of China has issued 6 editions of the COVID-19 Diagnosis and Treatment Program. According to the medical observation period
the clinical treatment period
the severe period and the recovery period
traditional Chinese medicine treatment regimens are recommended. Chinese patent medicine is the important component in the treatment regimen of traditional Chinese medicine. Four kinds of oral Chinese patent medicine are recommended in the medical observation period
including Huoxiang Zhengqi capsules( pills
liquid and oral liquid)
Jinhua Qinggan granules
Lianhua Qingwen capsules and Shufeng Jiedu capsules. This article reviews the literature related to traditional Chinese medicine treatment
clinical research and medication safety
so as to provide reference for rational drug use in the prevention and treatment of COVID-19.
关键词
诊疗方案COVID-19中成药医学观察期
Keywords
Diagnosis and treatment regimensCOVID-19Chinese patent medicineMedical observation period